Literature DB >> 12916936

A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells.

Bhas A Dani1, Adrian T Raiche, David A Puleo, Patrick P DeLuca.   

Abstract

The purpose of this study was to evaluate salmon calcitonin (sCT) microspheres in vitro for their antiresorptive activity using cultured osteoclastic cells. The antiresorptive activity of sCT-loaded microspheres, prepared from a low molecular weight hydrophilic poly (lactide-co-glycolide) polymer (PLGA), was studied using bone marrow culture cells harvested from juvenile rats and cultured on slices of devitalized bone for up to 4 weeks. The resorptive activity of osteoclastic cells was quantified in terms of number and type of resorption pits and total area of resorption. Microspheres containing 5.1% sCT released 70% peptide in 2 weeks and 88% in 4 weeks. All sCT treatments inhibited total resorptive activity. A dose-dependent decrease in resorption was observed with sCT microspheres at 2 weeks. The high dose (10 mg of microspheres) produced a 99.5% decrease in resorption at 3 weeks, while the low dose (1 mg) produced an 80% reduction. Exposure of cultures to soluble sCT and sCT-loaded microspheres caused a decrease in the number of large pits, which were the predominant type formed in control cultures. Thus, this system could serve as an in vitro method to evaluate the antiresorptive effect of PLGA-sCT microspheres.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916936      PMCID: PMC2784050          DOI: 10.1208/pt030321

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  14 in total

1.  Osteoblasts on hydroxyapatite, alumina and bone surfaces in vitro: morphology during the first 2 h of attachment.

Authors:  M A Malik; D A Puleo; R Bizios; R H Doremus
Journal:  Biomaterials       Date:  1992       Impact factor: 12.479

2.  A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.

Authors:  K Sugawara; M Hamada; S Hosoi; T Tamaoki
Journal:  Anal Biochem       Date:  1998-01-15       Impact factor: 3.365

3.  [Study of the hypocalcemic mechanism of action of thyrocalcitonin].

Authors:  G Milhaud; A M Perault; M S Moukhtar
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1965-07-19

4.  [Interaction of thyrocalcitonin and parathyroid hormone].

Authors:  H Kohler
Journal:  Schweiz Med Wochenschr       Date:  1968-05-11

Review 5.  Cells of bone: proliferation, differentiation, and hormonal regulation.

Authors:  P J Nijweide; E H Burger; J H Feyen
Journal:  Physiol Rev       Date:  1986-10       Impact factor: 37.312

6.  The sensitivity of isolated osteoclasts to morphological transformation by calcitonin.

Authors:  T J Chambers; A Moore
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

7.  The mode of action of thyrocalcitonin.

Authors:  T J Martin; C J Robinson; I MacIntyre
Journal:  Lancet       Date:  1966-04-23       Impact factor: 79.321

8.  Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.

Authors:  B A Dani; P P DeLuca
Journal:  AAPS PharmSciTech       Date:  2001-10-17       Impact factor: 3.246

9.  Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.

Authors:  R Huwyler; W Born; E E Ohnhaus; J A Fischer
Journal:  Am J Physiol       Date:  1979-01

10.  Identification of a functional mononuclear precursor of the osteoclast in chicken medullary bone marrow cultures.

Authors:  B Prallet; P Male; L Neff; R Baron
Journal:  J Bone Miner Res       Date:  1992-04       Impact factor: 6.741

View more
  1 in total

Review 1.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.